Sanmina Corp

SANM

Sanmina Corporation (SANM) is a global leader in integrated manufacturing solutions, providing end-to-end design, fabrication, assembly, and testing services for electronics and hardware products. The company serves various industries including communications, computing, healthcare, defense, and industrial markets, offering customized manufacturing and supply chain solutions.

$197.24 -0.81 (-0.41%)
🚫 Sanmina Corp does not pay dividends

Company News

AMD Reveals A $6.5 Million Marvell Bet That's Already Soaring
Benzinga • Erica Kollmann • May 13, 2026

AMD disclosed a $6.5 million stake in Marvell Technology through its latest 13F filing, with the position showing an estimated unrealized gain of approximately $4.3 million as Marvell shares have risen about 66% from AMD's implied entry price. The investment reflects AMD's exposure to AI infrastructure and data center semiconductor opportunities....

Trends and Strategies in the 2026 Medical Device CMDO Market: Revenue to Exceed $354 Billion by 2033
GlobeNewswire Inc. • Researchandmarkets.Com • April 28, 2026

The global medical device contract development and manufacturing organization (CDMO) market is expected to expand significantly at a CAGR of 13.12% from 2026 to 2033, driven by increased outsourcing by OEMs, demand for advanced connected devices, and the shift toward home care and minimally invasive treatments. CDMOs are becoming essential partne...

Why Sanmina Stock Plummeted by Almost 22% Today
The Motley Fool • Eric Volkman • January 28, 2026

Sanmina's stock dropped nearly 22% despite beating earnings estimates on both revenue ($3.19B vs $3.09B expected) and net income ($2.38 per share vs $2.14 expected). The sharp decline was driven by disappointing forward guidance, with the company projecting Q2 net sales of $3.1-$3.4 billion, falling short of analyst expectations of $3.52 billion....

Why Sanmina Stock Just Got Sacked
The Motley Fool • Rich Smith • December 16, 2025

Sanmina plans a new factory in Texas targeting the U.S. energy market and partnered with a Croatian company to co-design transformers, but investors are concerned about potential cash burn and high valuation.

IVD Contract Manufacturing Market Size to Worth USD 56.90 Billion, Rising at 10.44% CAGR by 2034
GlobeNewswire Inc. • Towards Healthcare • October 27, 2025

The global In-Vitro Diagnostic (IVD) contract manufacturing market is projected to grow from USD 21.13 billion in 2024 to USD 56.9 billion by 2034, driven by increasing demand for advanced diagnostic tests and rising chronic disease prevalence.

Related Companies